4-o-methyl-12-o-tetradecanoylphorbol 13-acetate has been researched along with Atherosclerosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Al-Sharea, A; Choi, JSY; de Haan, JB; Jandeleit-Dahm, K; Mukhamedova, N; Murphy, AJ; Ritchie, RH; Sharma, A; Simpson, DS; Stefanovic, N; Sviridov, D; Vince, JE | 1 |
1 other study(ies) available for 4-o-methyl-12-o-tetradecanoylphorbol 13-acetate and Atherosclerosis
Article | Year |
---|---|
Specific NLRP3 Inhibition Protects Against Diabetes-Associated Atherosclerosis.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Blood Glucose; Cells, Cultured; Fluorescent Antibody Technique; Glucose; Humans; Immunohistochemistry; Inflammasomes; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Smooth Muscle; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Tetradecanoylphorbol Acetate; THP-1 Cells; Tumor Necrosis Factor-alpha | 2021 |